CD24 and breast carcinoma: While regulation of the CD24 promoter by methylation has been reported in diseased conjunctiva (Riau et al., 2011) and glioblastoma cell lines (Fukushima et al., 2007), there was no evidence of promoter methylation of CD24 in breast cancer cell lines or in patient tumors (Kagara et al., 2012).